Re: Rumored Copaxone clinical trial (follow-up to #msg-60673589)
I heard Teva was doing the trial, as Bill Marth and team want to prove to Wall Street/Analysts that it's impossible to obtain generic approval for Copaxone. :)
Dew... Approximately how long would a bio-equivalence study take (start to finish)? In your opinion, what are the chances the study is being conducted by someone other than Sandoz/MNTA? TIA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.